Form 4: AbbVie HR Chief Sells Shares for Tax Obligations
Insider Transaction Report
AbbVie's EVP, Chief HR Officer, Demetris D. Crum, disposed of 1,594 shares of common stock to cover tax withholding obligations.
Summary
- Demetris D. Crum, Executive Vice President and Chief Human Resources Officer of AbbVie Inc., reported a transaction involving company common stock.
- On February 27, 2026, Crum disposed of 1,594 shares of AbbVie common stock.
- The shares were disposed of at a price of $232.08 per share.
- This transaction was identified as a disposition to the issuer to satisfy tax withholding obligations (Transaction Code 'F').
- Following this transaction, Crum directly beneficially owns 7,914 shares of AbbVie common stock.
- The transaction was made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event. It is a routine insider transaction for tax purposes, which is a standard part of executive compensation and does not indicate a change in company fundamentals or executive sentiment.
Future Outlook
The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.
Industry Context
StockSavvy.ai notes that routine insider transactions, such as sales to cover tax obligations, are common occurrences in publicly traded companies, particularly for executives receiving equity-based compensation. These transactions typically do not reflect a change in management's outlook on the company's fundamentals but rather a standard financial planning activity.
Related Party Transactions
- Demetris D. Crum, an executive officer of AbbVie Inc., disposed of shares of the company's common stock to the issuer to satisfy tax withholding obligations.
Stakeholder Impact
- Shareholders: The transaction is a routine insider sale for tax purposes and is unlikely to have a significant direct impact on the broader shareholder base.
- Employees: No direct impact on employees is indicated by this filing.
Key Dates
| Date | Description |
|---|---|
| 02/27/2026 | Date of transaction where 1,594 shares were disposed of. |
| 03/06/2026 | Date the Statement of Changes in Beneficial Ownership (Form 4) was signed. |
Keywords
AbbVie, ABBV, Form 4, Insider Trading, Stock Sale, Tax Withholding, Executive Compensation, Demetris D. Crum
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.